Miki, G.; Kuroishi, N.; Tokashiki, M.; Nagata, S.; Tamura, M.; Yoshiya, T.; Yoshizawa-Kumagaye, K.; Ashizuka, S.; Kato, J.; Yamasaki, M.;
et al. 20 kDa PEGylated Adrenomedullin as a New Therapeutic Candidate for Inflammatory Bowel Disease. Gastrointest. Disord. 2020, 2, 366-377.
https://doi.org/10.3390/gidisord2040033
AMA Style
Miki G, Kuroishi N, Tokashiki M, Nagata S, Tamura M, Yoshiya T, Yoshizawa-Kumagaye K, Ashizuka S, Kato J, Yamasaki M,
et al. 20 kDa PEGylated Adrenomedullin as a New Therapeutic Candidate for Inflammatory Bowel Disease. Gastrointestinal Disorders. 2020; 2(4):366-377.
https://doi.org/10.3390/gidisord2040033
Chicago/Turabian Style
Miki, Goro, Nobuko Kuroishi, Mariko Tokashiki, Sayaka Nagata, Masaji Tamura, Taku Yoshiya, Kumiko Yoshizawa-Kumagaye, Shinya Ashizuka, Joji Kato, Motoo Yamasaki,
and et al. 2020. "20 kDa PEGylated Adrenomedullin as a New Therapeutic Candidate for Inflammatory Bowel Disease" Gastrointestinal Disorders 2, no. 4: 366-377.
https://doi.org/10.3390/gidisord2040033
APA Style
Miki, G., Kuroishi, N., Tokashiki, M., Nagata, S., Tamura, M., Yoshiya, T., Yoshizawa-Kumagaye, K., Ashizuka, S., Kato, J., Yamasaki, M., & Kitamura, K.
(2020). 20 kDa PEGylated Adrenomedullin as a New Therapeutic Candidate for Inflammatory Bowel Disease. Gastrointestinal Disorders, 2(4), 366-377.
https://doi.org/10.3390/gidisord2040033
